Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 continuation trial of adjunctive asenapine versus placebo with lithium or valproate in bipolar I disorder
2005-001472-12Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Asenapine + mood stabilizer with Placebo + mood stabilizer (2 arms). Primary endpoints: Long-term safety and tolerability, Maintenance of effect on Young Mania Rating Scale and 1 more. Started Dec 2005; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2005-001472-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001472-12.